MODULATING CO-STIMULATION DURING ANTIGEN PRESENTATION TO ENHANCE CANCER IMMUNOTHERAPY

Por Liechtenstein, Therese, Dufait, Ines, Lanna, Alessio, Breckpot, Karine, Escors, David
Publicado em 2012

PD-L1/PD-1 Co-Stimulation, a Brake for T cell Activation and a T cell Differentiation Signal

Por Liechtenstein, Therese, Dufait, Ines, Bricogne, Christopher, Lanna, Alessio, Pen, Joeri, Breckpot, Karine, Escors, David
Publicado em 2012

Signal transducer and activator of transcription 3 in myeloid-derived suppressor cells: an opportunity for cancer therapy

Por Dufait, Inès, Van Valckenborgh, Els, Menu, Eline, Escors, David, De Ridder, Mark, Breckpot, Karine
Publicado no Oncotarget (2016)

Retroviral and Lentiviral Vectors for the Induction of Immunological Tolerance

Por Dufait, Inès, Liechtenstein, Therese, Lanna, Alessio, Bricogne, Christopher, Laranga, Roberta, Padella, Antonella, Breckpot, Karine, Escors, David
Publicado em 2012

Ex vivo generation of myeloid-derived suppressor cells that model the tumor immunosuppressive environment in colorectal cancer

Por Dufait, Inès, Schwarze, Julia Katharina, Liechtenstein, Therese, Leonard, Wim, Jiang, Heng, Escors, David, De Ridder, Mark, Breckpot, Karine
Publicado no Oncotarget (2015)

Anti-melanoma vaccines engineered to simultaneously modulate cytokine priming and silence PD-L1 characterized using ex vivo myeloid-derived suppressor cells as a readout of therape...

Por Liechtenstein, Therese, Perez-Janices, Noemi, Blanco-Luquin, Idoia, Goyvaerts, Cleo, Schwarze, Julia, Dufait, Ines, Lanna, Alessio, Ridder, Mark De, Guerrero-Setas, David, Breckpot, Karine, Escors, David
Publicado no Oncoimmunology (2014)

Assessing T-cell responses in anticancer immunotherapy: Dendritic cells or myeloid-derived suppressor cells?

Por Escors, David, Liechtenstein, Therese, Perez-Janices, Noemi, Schwarze, Julia, Dufait, Ines, Goyvaerts, Cleo, Lanna, Alessio, Arce, Frederick, Blanco-Luquin, Idoia, Kochan, Grazyna, Guerrero-Setas, David, Breckpot, Karine
Publicado em 2013

Auranofin radiosensitizes tumor cells through targeting thioredoxin reductase and resulting overproduction of reactive oxygen species

Por Wang, Hui, Bouzakoura, Soumaya, de Mey, Sven, Jiang, Heng, Law, Kalun, Dufait, Inès, Corbet, Cyril, Verovski, Valeri, Gevaert, Thierry, Feron, Olivier, Van den Berge, Dirk, Storme, Guy, De Ridder, Mark
Publicado no Oncotarget (2017)